These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 32785054)

  • 1. Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor.
    Kleinau G; Heyder NA; Tao YX; Scheerer P
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans.
    Srinivasan S; Lubrano-Berthelier C; Govaerts C; Picard F; Santiago P; Conklin BR; Vaisse C
    J Clin Invest; 2004 Oct; 114(8):1158-64. PubMed ID: 15489963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of MAPK by inverse agonists in six naturally occurring constitutively active mutant human melanocortin-4 receptors.
    Mo XL; Tao YX
    Biochim Biophys Acta; 2013 Dec; 1832(12):1939-48. PubMed ID: 23791567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure of MC4R to agonist in the endoplasmic reticulum stabilizes an active conformation of the receptor that does not desensitize.
    Granell S; Molden BM; Baldini G
    Proc Natl Acad Sci U S A; 2013 Dec; 110(49):E4733-42. PubMed ID: 24248383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Signaling Profiles of MC4R Mutations with Three Different Ligands.
    Paisdzior S; Dimitriou IM; Schöpe PC; Annibale P; Scheerer P; Krude H; Lohse MJ; Biebermann H; Kühnen P
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective.
    Heyder N; Kleinau G; Szczepek M; Kwiatkowski D; Speck D; Soletto L; Cerdá-Reverter JM; Krude H; Kühnen P; Biebermann H; Scheerer P
    Front Endocrinol (Lausanne); 2019; 10():515. PubMed ID: 31417496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of feline melanocortin 4 receptor and melanocortin 2 receptor accessory protein 2.
    Habara M; Mori N; Okada Y; Kawasumi K; Nakao N; Tanaka Y; Arai T; Yamamoto I
    Gen Comp Endocrinol; 2018 May; 261():31-39. PubMed ID: 29360464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
    Haskell-Luevano C; Cone RD; Monck EK; Wan YP
    Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist.
    Xiang Z; Proneth B; Dirain ML; Litherland SA; Haskell-Luevano C
    Biochemistry; 2010 Jun; 49(22):4583-600. PubMed ID: 20462274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure elucidation of a human melanocortin-4 receptor specific orthosteric nanobody agonist.
    Fontaine T; Busch A; Laeremans T; De Cesco S; Liang YL; Jaakola VP; Sands Z; Triest S; Masiulis S; Dekeyzer L; Samyn N; Loeys N; Perneel L; Debaere M; Martini M; Vantieghem C; Virmani R; Skieterska K; Staelens S; Barroco R; Van Roy M; Menet C
    Nat Commun; 2024 Oct; 15(1):7029. PubMed ID: 39353917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist.
    Xiang Z; Litherland SA; Sorensen NB; Proneth B; Wood MS; Shaw AM; Millard WJ; Haskell-Luevano C
    Biochemistry; 2006 Jun; 45(23):7277-88. PubMed ID: 16752916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common requirements for melanocortin-4 receptor selectivity of structurally unrelated melanocortin agonist and endogenous antagonist, Agouti protein.
    Oosterom J; Garner KM; den Dekker WK ; Nijenhuis WA; Gispen WH; Burbach JP; Barsh GS; Adan RA
    J Biol Chem; 2001 Jan; 276(2):931-6. PubMed ID: 11024027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-protein-independent coupling of MC4R to Kir7.1 in hypothalamic neurons.
    Ghamari-Langroudi M; Digby GJ; Sebag JA; Millhauser GL; Palomino R; Matthews R; Gillyard T; Panaro BL; Tough IR; Cox HM; Denton JS; Cone RD
    Nature; 2015 Apr; 520(7545):94-8. PubMed ID: 25600267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal cAMP Signaling Selectivity by Natural and Synthetic MC4R Agonists.
    Molden BM; Cooney KA; West K; Van Der Ploeg LH; Baldini G
    Mol Endocrinol; 2015 Nov; 29(11):1619-33. PubMed ID: 26418335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization.
    Shinyama H; Masuzaki H; Fang H; Flier JS
    Endocrinology; 2003 Apr; 144(4):1301-14. PubMed ID: 12639913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach.
    Falls BA; Zhang Y
    ACS Chem Neurosci; 2019 Mar; 10(3):1055-1065. PubMed ID: 30048591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural inverse agonist agouti-related protein induces arrestin-mediated endocytosis of melanocortin-3 and -4 receptors.
    Breit A; Wolff K; Kalwa H; Jarry H; Büch T; Gudermann T
    J Biol Chem; 2006 Dec; 281(49):37447-56. PubMed ID: 17041250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of melanocortin-4 receptor for AGRP inverse agonism.
    Chen M; Celik A; Georgeson KE; Harmon CM; Yang Y
    Regul Pept; 2006 Sep; 136(1-3):40-9. PubMed ID: 16820227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal pathway analysis of selected obesity-associated melanocortin-4 receptor class V mutants.
    Sharma S; Thibodeau S; Lytton J
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165835. PubMed ID: 32423884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.